Feeding	O
Angptl4	B:C1423931
-/-	I:C1423931
mice	O
trans	O
fat	I:C1257879
promotes	O
foam	O
cell	I:C0016390
formation	O
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
without	O
leading	O
to	O
ascites	O
ANGPTL4	O
regulates	O
plasma	O
triglyceride	O
levels	O
by	O
inhibiting	O
lipoprotein	O
lipase	I:C0023816
.	O

Feeding	O
Angptl4	O
-/-	I:C1423931
mice	B:C0206745
trans	O
fat	I:C1257879
promotes	O
foam	O
cell	I:C0016390
formation	O
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
without	O
leading	O
to	O
ascites	O
ANGPTL4	O
regulates	O
plasma	O
triglyceride	O
levels	O
by	O
inhibiting	O
lipoprotein	O
lipase	I:C0023816
.	O

Feeding	O
Angptl4	O
-/-	I:C1423931
mice	O
trans	B:C1257879
fat	I:C1257879
promotes	O
foam	O
cell	I:C0016390
formation	O
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
without	O
leading	O
to	O
ascites	O
ANGPTL4	O
regulates	O
plasma	O
triglyceride	O
levels	O
by	O
inhibiting	O
lipoprotein	O
lipase	I:C0023816
.	O

Feeding	O
Angptl4	O
-/-	I:C1423931
mice	O
trans	O
fat	I:C1257879
promotes	O
foam	B:C0016390
cell	I:C0016390
formation	O
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
without	O
leading	O
to	O
ascites	O
ANGPTL4	O
regulates	O
plasma	O
triglyceride	O
levels	O
by	O
inhibiting	O
lipoprotein	O
lipase	I:C0023816
.	O

Feeding	O
Angptl4	O
-/-	I:C1423931
mice	O
trans	O
fat	I:C1257879
promotes	O
foam	O
cell	I:C0016390
formation	O
in	O
mesenteric	B:C0229792
lymph	I:C0229792
nodes	I:C0229792
without	O
leading	O
to	O
ascites	O
ANGPTL4	O
regulates	O
plasma	O
triglyceride	O
levels	O
by	O
inhibiting	O
lipoprotein	O
lipase	I:C0023816
.	O

Feeding	O
Angptl4	O
-/-	I:C1423931
mice	O
trans	O
fat	I:C1257879
promotes	O
foam	O
cell	I:C0016390
formation	O
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
without	O
leading	O
to	O
ascites	B:C0003962
ANGPTL4	O
regulates	O
plasma	O
triglyceride	O
levels	O
by	O
inhibiting	O
lipoprotein	O
lipase	I:C0023816
.	O

Feeding	O
Angptl4	O
-/-	I:C1423931
mice	O
trans	O
fat	I:C1257879
promotes	O
foam	O
cell	I:C0016390
formation	O
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
without	O
leading	O
to	O
ascites	O
ANGPTL4	B:C1438918
regulates	O
plasma	O
triglyceride	O
levels	O
by	O
inhibiting	O
lipoprotein	O
lipase	I:C0023816
.	O

Feeding	O
Angptl4	O
-/-	I:C1423931
mice	O
trans	O
fat	I:C1257879
promotes	O
foam	O
cell	I:C0016390
formation	O
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
without	O
leading	O
to	O
ascites	O
ANGPTL4	O
regulates	O
plasma	B:C0032105
triglyceride	O
levels	O
by	O
inhibiting	O
lipoprotein	O
lipase	I:C0023816
.	O

Feeding	O
Angptl4	O
-/-	I:C1423931
mice	O
trans	O
fat	I:C1257879
promotes	O
foam	O
cell	I:C0016390
formation	O
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
without	O
leading	O
to	O
ascites	O
ANGPTL4	O
regulates	O
plasma	O
triglyceride	B:C0041004
levels	O
by	O
inhibiting	O
lipoprotein	O
lipase	I:C0023816
.	O

Feeding	O
Angptl4	O
-/-	I:C1423931
mice	O
trans	O
fat	I:C1257879
promotes	O
foam	O
cell	I:C0016390
formation	O
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
without	O
leading	O
to	O
ascites	O
ANGPTL4	O
regulates	O
plasma	O
triglyceride	O
levels	O
by	O
inhibiting	O
lipoprotein	B:C0023816
lipase	I:C0023816
.	O

Inactivation	B:C0598496
of	O
ANGPTL4	O
decreases	O
plasma	O
triglycerides	O
and	O
reduces	O
risk	O
of	O
coronary	O
artery	I:C0010068
disease	I:C0010068
.	O

Inactivation	O
of	O
ANGPTL4	B:C1438918
decreases	O
plasma	O
triglycerides	O
and	O
reduces	O
risk	O
of	O
coronary	O
artery	I:C0010068
disease	I:C0010068
.	O

Inactivation	O
of	O
ANGPTL4	O
decreases	O
plasma	B:C0032105
triglycerides	O
and	O
reduces	O
risk	O
of	O
coronary	O
artery	I:C0010068
disease	I:C0010068
.	O

Inactivation	O
of	O
ANGPTL4	O
decreases	O
plasma	O
triglycerides	B:C0041004
and	O
reduces	O
risk	O
of	O
coronary	O
artery	I:C0010068
disease	I:C0010068
.	O

Inactivation	O
of	O
ANGPTL4	O
decreases	O
plasma	O
triglycerides	O
and	O
reduces	O
risk	O
of	O
coronary	B:C0010068
artery	I:C0010068
disease	I:C0010068
.	O

Unfortunately	O
,	O
targeting	O
ANGPTL4	B:C1438918
for	O
the	O
therapeutic	O
management	O
of	O
dyslipidemia	O
and	O
atherosclerosis	O
is	O
hampered	O
by	O
the	O
observation	O
that	O
mice	O
and	O
monkeys	O
in	O
which	O
ANGPTL4	O
is	O
inactivated	O
exhibit	O
lipid	O
accumulation	I:C0333574
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
.	O

Unfortunately	O
,	O
targeting	O
ANGPTL4	O
for	O
the	O
therapeutic	O
management	B:C0086388
of	O
dyslipidemia	O
and	O
atherosclerosis	O
is	O
hampered	O
by	O
the	O
observation	O
that	O
mice	O
and	O
monkeys	O
in	O
which	O
ANGPTL4	O
is	O
inactivated	O
exhibit	O
lipid	O
accumulation	I:C0333574
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
.	O

Unfortunately	O
,	O
targeting	O
ANGPTL4	O
for	O
the	O
therapeutic	O
management	O
of	O
dyslipidemia	B:C0242339
and	O
atherosclerosis	O
is	O
hampered	O
by	O
the	O
observation	O
that	O
mice	O
and	O
monkeys	O
in	O
which	O
ANGPTL4	O
is	O
inactivated	O
exhibit	O
lipid	O
accumulation	I:C0333574
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
.	O

Unfortunately	O
,	O
targeting	O
ANGPTL4	O
for	O
the	O
therapeutic	O
management	O
of	O
dyslipidemia	O
and	O
atherosclerosis	B:C0004153
is	O
hampered	O
by	O
the	O
observation	O
that	O
mice	O
and	O
monkeys	O
in	O
which	O
ANGPTL4	O
is	O
inactivated	O
exhibit	O
lipid	O
accumulation	I:C0333574
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
.	O

Unfortunately	O
,	O
targeting	O
ANGPTL4	O
for	O
the	O
therapeutic	O
management	O
of	O
dyslipidemia	O
and	O
atherosclerosis	O
is	O
hampered	O
by	O
the	O
observation	O
that	O
mice	B:C0025929
and	O
monkeys	O
in	O
which	O
ANGPTL4	O
is	O
inactivated	O
exhibit	O
lipid	O
accumulation	I:C0333574
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
.	O

Unfortunately	O
,	O
targeting	O
ANGPTL4	O
for	O
the	O
therapeutic	O
management	O
of	O
dyslipidemia	O
and	O
atherosclerosis	O
is	O
hampered	O
by	O
the	O
observation	O
that	O
mice	O
and	O
monkeys	B:C0026447
in	O
which	O
ANGPTL4	O
is	O
inactivated	O
exhibit	O
lipid	O
accumulation	I:C0333574
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
.	O

Unfortunately	O
,	O
targeting	O
ANGPTL4	O
for	O
the	O
therapeutic	O
management	O
of	O
dyslipidemia	O
and	O
atherosclerosis	O
is	O
hampered	O
by	O
the	O
observation	O
that	O
mice	O
and	O
monkeys	O
in	O
which	O
ANGPTL4	B:C1438918
is	O
inactivated	O
exhibit	O
lipid	O
accumulation	I:C0333574
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
.	O

Unfortunately	O
,	O
targeting	O
ANGPTL4	O
for	O
the	O
therapeutic	O
management	O
of	O
dyslipidemia	O
and	O
atherosclerosis	O
is	O
hampered	O
by	O
the	O
observation	O
that	O
mice	O
and	O
monkeys	O
in	O
which	O
ANGPTL4	O
is	O
inactivated	O
exhibit	O
lipid	B:C0333574
accumulation	I:C0333574
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
.	O

Unfortunately	O
,	O
targeting	O
ANGPTL4	O
for	O
the	O
therapeutic	O
management	O
of	O
dyslipidemia	O
and	O
atherosclerosis	O
is	O
hampered	O
by	O
the	O
observation	O
that	O
mice	O
and	O
monkeys	O
in	O
which	O
ANGPTL4	O
is	O
inactivated	O
exhibit	O
lipid	O
accumulation	I:C0333574
in	O
mesenteric	B:C0229792
lymph	I:C0229792
nodes	I:C0229792
.	O

In	O
mice	B:C0025929
these	O
pathological	O
events	O
exclusively	O
unfold	O
upon	O
feeding	O
a	O
high	O
saturated	I:C0597423
fatty	I:C0597423
acid	I:C0597423
diet	O
and	O
are	O
followed	O
by	O
an	O
ultimately	O
lethal	O
pro-inflammatory	O
response	I:C1155266
and	O
chylous	O
ascites	I:C0008732
.	O

In	O
mice	O
these	O
pathological	O
events	O
exclusively	O
unfold	O
upon	O
feeding	O
a	O
high	B:C0597423
saturated	I:C0597423
fatty	I:C0597423
acid	I:C0597423
diet	O
and	O
are	O
followed	O
by	O
an	O
ultimately	O
lethal	O
pro-inflammatory	O
response	I:C1155266
and	O
chylous	O
ascites	I:C0008732
.	O

In	O
mice	O
these	O
pathological	O
events	O
exclusively	O
unfold	O
upon	O
feeding	O
a	O
high	O
saturated	I:C0597423
fatty	I:C0597423
acid	I:C0597423
diet	B:C0012155
and	O
are	O
followed	O
by	O
an	O
ultimately	O
lethal	O
pro-inflammatory	O
response	I:C1155266
and	O
chylous	O
ascites	I:C0008732
.	O

In	O
mice	O
these	O
pathological	O
events	O
exclusively	O
unfold	O
upon	O
feeding	O
a	O
high	O
saturated	I:C0597423
fatty	I:C0597423
acid	I:C0597423
diet	O
and	O
are	O
followed	O
by	O
an	O
ultimately	O
lethal	B:C3151529
pro-inflammatory	O
response	I:C1155266
and	O
chylous	O
ascites	I:C0008732
.	O

In	O
mice	O
these	O
pathological	O
events	O
exclusively	O
unfold	O
upon	O
feeding	O
a	O
high	O
saturated	I:C0597423
fatty	I:C0597423
acid	I:C0597423
diet	O
and	O
are	O
followed	O
by	O
an	O
ultimately	O
lethal	O
pro-inflammatory	B:C1155266
response	I:C1155266
and	O
chylous	O
ascites	I:C0008732
.	O

In	O
mice	O
these	O
pathological	O
events	O
exclusively	O
unfold	O
upon	O
feeding	O
a	O
high	O
saturated	I:C0597423
fatty	I:C0597423
acid	I:C0597423
diet	O
and	O
are	O
followed	O
by	O
an	O
ultimately	O
lethal	O
pro-inflammatory	O
response	I:C1155266
and	O
chylous	B:C0008732
ascites	I:C0008732
.	O

Here	O
we	O
show	O
that	O
Angptl4	B:C1423931
-/-	I:C1423931
mice	O
fed	O
a	O
diet	O
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	O
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	B:C0206745
fed	O
a	O
diet	O
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	O
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
diet	B:C0012155
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	O
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
diet	O
rich	O
in	O
trans	B:C1257879
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	O
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
diet	O
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	B:C0023779
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	O
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
diet	O
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	B:C0016390
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	O
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
diet	O
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	B:C0229792
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	O
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
diet	O
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	B:C0229671
amyloid	O
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
diet	O
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	B:C0002716
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
diet	O
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	O
and	O
haptoglobin	B:C0018595
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
diet	O
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	O
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	B:C0003962
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
diet	O
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	O
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	B:C1423931
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
diet	O
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	O
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	B:C0206745
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
diet	O
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	O
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	B:C0597423
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	O
.	O

Here	O
we	O
show	O
that	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
diet	O
rich	O
in	O
trans	O
fatty	I:C1257879
acids	I:C1257879
develop	O
numerous	O
lipid	O
-	O
filled	O
giant	O
cells	I:C0016390
in	O
their	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
,	O
yet	O
do	O
not	O
have	O
elevated	O
serum	O
amyloid	O
and	O
haptoglobin	O
,	O
do	O
not	O
exhibit	O
ascites	O
,	O
and	O
survive	O
,	O
unlike	O
Angptl4	O
-/-	I:C1423931
mice	O
fed	O
a	O
saturated	O
fatty	I:C0597423
acid	I:C0597423
-	O
rich	O
diet	B:C0012155
.	O

In	O
RAW264.7	B:C0024432
macrophages	I:C0024432
the	O
saturated	O
fatty	I:C3503116
acid	I:C3503116
palmitate	I:C3503116
markedly	O
increases	O
markers	O
of	O
inflammation	O
and	O
the	O
unfolded	O
protein	I:C1155342
response	I:C1155342
,	O
whereas	O
the	O
trans	O
-	I:C3886672
unsaturated	I:C3886672
elaidate	I:C3886672
and	O
the	O
cis-unsaturated	O
oleate	I:C0220884
have	O
the	O
opposite	O
effect	O
.	O

In	O
RAW264.7	O
macrophages	I:C0024432
the	O
saturated	B:C3503116
fatty	I:C3503116
acid	I:C3503116
palmitate	I:C3503116
markedly	O
increases	O
markers	O
of	O
inflammation	O
and	O
the	O
unfolded	O
protein	I:C1155342
response	I:C1155342
,	O
whereas	O
the	O
trans	O
-	I:C3886672
unsaturated	I:C3886672
elaidate	I:C3886672
and	O
the	O
cis-unsaturated	O
oleate	I:C0220884
have	O
the	O
opposite	O
effect	O
.	O

In	O
RAW264.7	O
macrophages	I:C0024432
the	O
saturated	O
fatty	I:C3503116
acid	I:C3503116
palmitate	I:C3503116
markedly	O
increases	O
markers	B:C0005516
of	O
inflammation	O
and	O
the	O
unfolded	O
protein	I:C1155342
response	I:C1155342
,	O
whereas	O
the	O
trans	O
-	I:C3886672
unsaturated	I:C3886672
elaidate	I:C3886672
and	O
the	O
cis-unsaturated	O
oleate	I:C0220884
have	O
the	O
opposite	O
effect	O
.	O

In	O
RAW264.7	O
macrophages	I:C0024432
the	O
saturated	O
fatty	I:C3503116
acid	I:C3503116
palmitate	I:C3503116
markedly	O
increases	O
markers	O
of	O
inflammation	B:C0021368
and	O
the	O
unfolded	O
protein	I:C1155342
response	I:C1155342
,	O
whereas	O
the	O
trans	O
-	I:C3886672
unsaturated	I:C3886672
elaidate	I:C3886672
and	O
the	O
cis-unsaturated	O
oleate	I:C0220884
have	O
the	O
opposite	O
effect	O
.	O

In	O
RAW264.7	O
macrophages	I:C0024432
the	O
saturated	O
fatty	I:C3503116
acid	I:C3503116
palmitate	I:C3503116
markedly	O
increases	O
markers	O
of	O
inflammation	O
and	O
the	O
unfolded	B:C1155342
protein	I:C1155342
response	I:C1155342
,	O
whereas	O
the	O
trans	O
-	I:C3886672
unsaturated	I:C3886672
elaidate	I:C3886672
and	O
the	O
cis-unsaturated	O
oleate	I:C0220884
have	O
the	O
opposite	O
effect	O
.	O

In	O
RAW264.7	O
macrophages	I:C0024432
the	O
saturated	O
fatty	I:C3503116
acid	I:C3503116
palmitate	I:C3503116
markedly	O
increases	O
markers	O
of	O
inflammation	O
and	O
the	O
unfolded	O
protein	I:C1155342
response	I:C1155342
,	O
whereas	O
the	O
trans	B:C3886672
-	I:C3886672
unsaturated	I:C3886672
elaidate	I:C3886672
and	O
the	O
cis-unsaturated	O
oleate	I:C0220884
have	O
the	O
opposite	O
effect	O
.	O

In	O
RAW264.7	O
macrophages	I:C0024432
the	O
saturated	O
fatty	I:C3503116
acid	I:C3503116
palmitate	I:C3503116
markedly	O
increases	O
markers	O
of	O
inflammation	O
and	O
the	O
unfolded	O
protein	I:C1155342
response	I:C1155342
,	O
whereas	O
the	O
trans	O
-	I:C3886672
unsaturated	I:C3886672
elaidate	I:C3886672
and	O
the	O
cis-unsaturated	B:C0220884
oleate	I:C0220884
have	O
the	O
opposite	O
effect	O
.	O

In	O
conclusion	O
,	O
trans	B:C1257879
and	O
saturated	O
fatty	I:C0597423
acids	I:C0597423
have	O
very	O
distinct	O
biological	O
effects	O
.	O

In	O
conclusion	O
,	O
trans	O
and	O
saturated	B:C0597423
fatty	I:C0597423
acids	I:C0597423
have	O
very	O
distinct	O
biological	O
effects	O
.	O

Furthermore	O
,	O
lipid	B:C0333574
accumulation	I:C0333574
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
is	O
uncoupled	O
from	O
activation	O
of	O
an	O
acute	O
-	I:C0001349
phase	I:C0001349
response	I:C0001349
and	O
chylous	O
ascites	I:C0008732
,	O
suggesting	O
that	O
ANGPTL4	O
should	O
not	O
be	O
fully	O
dismissed	O
as	O
target	O
for	O
dyslipidemia	O
.	O

Furthermore	O
,	O
lipid	O
accumulation	I:C0333574
in	O
mesenteric	B:C0229792
lymph	I:C0229792
nodes	I:C0229792
is	O
uncoupled	O
from	O
activation	O
of	O
an	O
acute	O
-	I:C0001349
phase	I:C0001349
response	I:C0001349
and	O
chylous	O
ascites	I:C0008732
,	O
suggesting	O
that	O
ANGPTL4	O
should	O
not	O
be	O
fully	O
dismissed	O
as	O
target	O
for	O
dyslipidemia	O
.	O

Furthermore	O
,	O
lipid	O
accumulation	I:C0333574
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
is	O
uncoupled	O
from	O
activation	O
of	O
an	O
acute	B:C0001349
-	I:C0001349
phase	I:C0001349
response	I:C0001349
and	O
chylous	O
ascites	I:C0008732
,	O
suggesting	O
that	O
ANGPTL4	O
should	O
not	O
be	O
fully	O
dismissed	O
as	O
target	O
for	O
dyslipidemia	O
.	O

Furthermore	O
,	O
lipid	O
accumulation	I:C0333574
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
is	O
uncoupled	O
from	O
activation	O
of	O
an	O
acute	O
-	I:C0001349
phase	I:C0001349
response	I:C0001349
and	O
chylous	B:C0008732
ascites	I:C0008732
,	O
suggesting	O
that	O
ANGPTL4	O
should	O
not	O
be	O
fully	O
dismissed	O
as	O
target	O
for	O
dyslipidemia	O
.	O

Furthermore	O
,	O
lipid	O
accumulation	I:C0333574
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
is	O
uncoupled	O
from	O
activation	O
of	O
an	O
acute	O
-	I:C0001349
phase	I:C0001349
response	I:C0001349
and	O
chylous	O
ascites	I:C0008732
,	O
suggesting	O
that	O
ANGPTL4	B:C1438918
should	O
not	O
be	O
fully	O
dismissed	O
as	O
target	O
for	O
dyslipidemia	O
.	O

Furthermore	O
,	O
lipid	O
accumulation	I:C0333574
in	O
mesenteric	O
lymph	I:C0229792
nodes	I:C0229792
is	O
uncoupled	O
from	O
activation	O
of	O
an	O
acute	O
-	I:C0001349
phase	I:C0001349
response	I:C0001349
and	O
chylous	O
ascites	I:C0008732
,	O
suggesting	O
that	O
ANGPTL4	O
should	O
not	O
be	O
fully	O
dismissed	O
as	O
target	O
for	O
dyslipidemia	B:C0242339
.	O

